Back
Catalyst Pharmaceuticals Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Buy
55
CPRX
Catalyst Pharmaceuticals
Last Price:
$21.26
Seasonality Move:
6.88%
7 Day Trial
ALL ACCESS PASS
$
7
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight buying pressure.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.56 | Sell |
| 20-day SMA: | 21.76 | Sell |
| 50-day SMA: | 21.71 | Sell |
| 200-day SMA: | 18.26 | Buy |
| 8-day EMA: | 21.55 | Sell |
| 20-day EMA: | 21.68 | Sell |
| 50-day EMA: | 21.43 | Sell |
| 200-day EMA: | 18.86 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 45.6 | Sell |
| Chaikin Money Flow: | 513844 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.15 - 22.07) | Sell |
| Bollinger Bands (100): | (19.14 - 22.14) | Buy |
Catalyst Pharmaceuticals Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 21.27 while CPRX 8-day simple moving average is 21.56, which is a Sell signal.
-
The stock price of CPRX is 21.27 while Catalyst Pharmaceuticals 20-day SMA is 21.76, which makes it a Sell.
-
Catalyst Pharmaceuticals 50-day simple moving average is 21.71 while CPRX share price is 21.27, making it a Sell technically.
-
CPRX stock price is 21.27 and Catalyst Pharmaceuticals 200-day simple moving average is 18.26, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
55
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a BuyThe current Catalyst Pharmaceuticals [CPRX] share price is $21.27. The Score for CPRX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.5B
Price in USD:
21.27
Share Volume:
1.7M
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
24.27
52-Week Low:
13.12
Buy
55
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?The Catalyst Pharmaceuticals stock price is 21.27 USD today.
-
Will CPRX stock go up or go down?Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Catalyst Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 21.27 while CPRX 8-day exponential moving average is 21.55, which is a Sell signal.
-
The stock price of CPRX is 21.27 while Catalyst Pharmaceuticals 20-day EMA is 21.68, which makes it a Sell.
-
Catalyst Pharmaceuticals 50-day exponential moving average is 21.43 while CPRX share price is 21.27, making it a Sell technically.
-
CPRX stock price is 21.27 and Catalyst Pharmaceuticals 200-day simple moving average is 18.86, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
-
CPRX Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Catalyst Pharmaceuticals is a Sell
-
Catalyst Pharmaceuticals Relative Strength Index (RSI) is 45.6, which suggest Catalyst Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Catalyst Pharmaceuticals is (21.15 - 22.07), which suggest Catalyst Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Catalyst Pharmaceuticals is (19.14 - 22.14), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.